Sakar et al. in a study on rats, showed the role of β-endorphin in the inhibition of tumor progression, presumably due to a reduction in the production of catecholamines and inflammatory cytokines such as IL-1α, IL-12, and tumor necrosis factor α (TNF-α). This evidence concerns the gene IL1A and neoplasm.